346 related articles for article (PubMed ID: 18201274)
1. Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer.
Yu X; Liu L; Cai B; He Y; Wan X
Cancer Sci; 2008 Mar; 99(3):543-52. PubMed ID: 18201274
[TBL] [Abstract][Full Text] [Related]
2. [Anoikis-suppression and invasion induced by tyrosine kinase receptor B in OVCAR3 ovarian cancer cells].
Yu XH; Yang YX; Cai B; Yan Q; He YY; Wan XP
Zhonghua Fu Chan Ke Za Zhi; 2008 Sep; 43(9):695-9. PubMed ID: 19087522
[TBL] [Abstract][Full Text] [Related]
3. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB.
Douma S; Van Laar T; Zevenhoven J; Meuwissen R; Van Garderen E; Peeper DS
Nature; 2004 Aug; 430(7003):1034-9. PubMed ID: 15329723
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine kinase B receptor and BDNF expression in ovarian cancers - Effect on cell migration, angiogenesis and clinical outcome.
Au CW; Siu MK; Liao X; Wong ES; Ngan HY; Tam KF; Chan DC; Chan QK; Cheung AN
Cancer Lett; 2009 Aug; 281(2):151-61. PubMed ID: 19307055
[TBL] [Abstract][Full Text] [Related]
5. Induction of anoikis and suppression of human ovarian tumor growth in vivo by down-regulation of Bcl-X(L).
Frankel A; Rosen K; Filmus J; Kerbel RS
Cancer Res; 2001 Jun; 61(12):4837-41. PubMed ID: 11406560
[TBL] [Abstract][Full Text] [Related]
6. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.
Jaboin J; Kim CJ; Kaplan DR; Thiele CJ
Cancer Res; 2002 Nov; 62(22):6756-63. PubMed ID: 12438277
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between EGFR and TrkB enhances ovarian cancer cell migration and proliferation.
Qiu L; Zhou C; Sun Y; Di W; Scheffler E; Healey S; Kouttab N; Chu W; Wan Y
Int J Oncol; 2006 Oct; 29(4):1003-11. PubMed ID: 16964397
[TBL] [Abstract][Full Text] [Related]
8. Critical role for TrkB kinase function in anoikis suppression, tumorigenesis, and metastasis.
Geiger TR; Peeper DS
Cancer Res; 2007 Jul; 67(13):6221-9. PubMed ID: 17616679
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y
Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358
[TBL] [Abstract][Full Text] [Related]
10. Implications of tropomyosin-related kinase B (TrkB) in head and neck cancer.
Zhu L; Werner JA; Mandic R
Anticancer Res; 2007; 27(5A):3121-6. PubMed ID: 17970052
[TBL] [Abstract][Full Text] [Related]
11. Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation.
Mawji IA; Simpson CD; Hurren R; Gronda M; Williams MA; Filmus J; Jonkman J; Da Costa RS; Wilson BC; Thomas MP; Reed JC; Glinsky GV; Schimmer AD
J Natl Cancer Inst; 2007 May; 99(10):811-22. PubMed ID: 17505076
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor induces anoikis resistance by up-regulation of cyclooxygenase-2 expression in uterine endometrial cancer cells.
Kanayama S; Yamada Y; Kawaguchi R; Tsuji Y; Haruta S; Kobayashi H
Oncol Rep; 2008 Jan; 19(1):117-22. PubMed ID: 18097584
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor protects cementoblasts from serum starvation-induced cell death.
Kajiya M; Shiba H; Fujita T; Takeda K; Uchida Y; Kawaguchi H; Kitagawa M; Takata T; Kurihara H
J Cell Physiol; 2009 Dec; 221(3):696-706. PubMed ID: 19711359
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of breast and ovarian cancer susceptibility gene 1 in chemosensitive human ovarian cancer cells does not involve the phosphatidylinositol 3'-kinase-Akt pathway.
Wang YQ; Zhang JR; Li SD; He YY; Yang YX; Liu XL; Wan XP
Cancer Sci; 2010 Jul; 101(7):1618-23. PubMed ID: 20487263
[TBL] [Abstract][Full Text] [Related]
15. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
Duan Z; Foster R; Bell DA; Mahoney J; Wolak K; Vaidya A; Hampel C; Lee H; Seiden MV
Clin Cancer Res; 2006 Sep; 12(17):5055-63. PubMed ID: 16951221
[TBL] [Abstract][Full Text] [Related]
16. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids.
Frankel A; Buckman R; Kerbel RS
Cancer Res; 1997 Jun; 57(12):2388-93. PubMed ID: 9192815
[TBL] [Abstract][Full Text] [Related]
17. Resistance to chemotherapy mediated by TrkB in neuroblastomas.
Ho R; Eggert A; Hishiki T; Minturn JE; Ikegaki N; Foster P; Camoratto AM; Evans AE; Brodeur GM
Cancer Res; 2002 Nov; 62(22):6462-6. PubMed ID: 12438236
[TBL] [Abstract][Full Text] [Related]
18. Small interference RNA-mediated suppression of overexpressed cyclin E protein restores G1/S regulation in NIH-OVCAR-3 ovarian cancer cells.
Todd MC; Spruill SC; Meerbrey KL
Int J Oncol; 2009 Aug; 35(2):375-80. PubMed ID: 19578752
[TBL] [Abstract][Full Text] [Related]
19. Dieldrin promotes resistance to anoikis in breast cancer cells in vitro.
Cameron HL; Foster WG
Reprod Toxicol; 2008 Feb; 25(2):256-62. PubMed ID: 18242054
[TBL] [Abstract][Full Text] [Related]
20. The neurotrophic receptor TrkB in anoikis resistance and metastasis: a perspective.
Geiger TR; Peeper DS
Cancer Res; 2005 Aug; 65(16):7033-6. PubMed ID: 16103047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
